+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fully MagLev Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127788
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Fully MagLev Ventricular Assist Device Market is projected to reach USD 735.49 Million in 2026. It is expected to continue growing at a CAGR of 15.67%, reaching USD 1.78 Billion by 2032.

Fully MagLev Ventricular Assist Devices: Executive Overview

Fully magnetically levitated ventricular assist devices use magnetic suspension to reduce mechanical contact within the blood pump. This design is intended to support durable circulatory assistance while addressing blood trauma, pump wear, and device reliability. Clinical adoption depends on evidence for survival, stroke prevention, bleeding reduction, infection management, quality of life, and safe long-term operation. Regulatory review, specialist-center capability, patient selection, and post-implant monitoring remain central to market development.

Clinical Engineering Shifts Are Reshaping Durable Mechanical Support

The landscape is shifting toward smaller, more hemocompatible pumps, improved implantability, and digitally enabled monitoring. Fully MagLev systems reflect a broader move from mechanically supported bearings toward contact-minimizing architectures. Important developments include better flow control, more durable driveline designs, improved surgical techniques, and protocols that integrate anticoagulation, rehabilitation, and infection prevention. Evidence standards are also becoming more demanding, with stakeholders placing greater emphasis on patient-reported outcomes and real-world durability alongside traditional clinical endpoints.

Artificial Intelligence Strengthens Monitoring, Selection, and Operational Decision-Making

Artificial intelligence can add value across the device lifecycle without replacing clinician oversight. Algorithms may help identify abnormal pump signals, detect emerging thrombosis or suction patterns, stratify adverse-event risk, and support individualized speed or therapy adjustments. AI-enabled analysis of imaging, laboratory data, and remote monitoring may also improve candidate selection and follow-up prioritization. Safe implementation requires representative clinical datasets, transparent validation, cybersecurity controls, human-review pathways, and clear accountability for device-related decisions.

Regional Conditions Determine Access, Evidence Generation, and Support Capacity

North America has strong advanced-heart-failure infrastructure, specialized implant centers, and established reimbursement pathways, while regulatory and payer evidence requirements remain rigorous. Europe combines sophisticated cardiac care with varied national reimbursement, procurement, and health-technology-assessment processes. Asia-Pacific includes advanced implant programs in Japan, Australia, South Korea, and selected Chinese centers, alongside substantial differences in access and specialist capacity. Latin America is shaped by uneven referral networks, public-private funding differences, and import dependence. The Middle East is building tertiary cardiac capabilities, particularly in well-resourced systems, while Africa continues to face constraints involving specialist availability, diagnostics, affordability, and long-term follow-up.

Economic and Institutional Groups Shape Procurement and Clinical Collaboration

ASEAN healthcare systems show varied cardiac-surgery capacity, creating opportunities for regional training and referral coordination but also requiring adaptable access models. BRICS members have substantial scientific and manufacturing capabilities, yet differ markedly in reimbursement, regulatory pathways, and availability of advanced-heart-failure services. The European Union benefits from cross-border research and common regulatory foundations, although national purchasing and reimbursement decisions remain distinct. G7 countries generally provide strong research ecosystems and specialist infrastructure, with continued pressure to demonstrate value and reduce complications. GCC states are expanding tertiary cardiac services and can support centralized expertise, while NATO members may benefit from interoperable research, procurement, and medical logistics networks.

Country-Level Priorities Range From Clinical Leadership to Capacity Building

The United States and Canada combine advanced implant programs with demanding evidence, reimbursement, and post-market surveillance requirements. The United Kingdom, Germany, France, Italy, and Spain have established specialist cardiac networks, but access is influenced by national assessment, procurement, and budget frameworks. Australia, Japan, and South Korea support sophisticated cardiovascular care and can contribute to clinical research and remote-monitoring development. China is expanding advanced cardiac capabilities while navigating domestic regulatory, manufacturing, and hospital-access priorities. India and Brazil are developing specialized services amid affordability and regional-access challenges. Mexico is strengthening tertiary care but continues to face uneven referral and follow-up capacity. Russia’s pathway is influenced by domestic health-system, technology-access, and specialized-care conditions.

Industry Leaders Should Prioritize Evidence, Reliability, and Equitable Care Pathways

Leaders should build evidence plans around clinically meaningful outcomes, including neurologic events, bleeding, infection, readmissions, functional status, and durability. Product development should pair hemocompatibility and compact design with dependable driveline management, intuitive controllers, and robust cybersecurity. Partnerships with implant centers can strengthen training, patient selection, and longitudinal registries. Market access strategies should address reimbursement, health-technology assessment, service infrastructure, and affordability rather than focusing only on device performance. AI programs should begin with validated monitoring use cases, auditable governance, and clinician-supervised deployment. Regional hubs, telemonitoring, and standardized transition-of-care protocols can improve continuity for patients outside major centers.

Methodology Combines Clinical Evidence, Regulatory Review, and Health-System Analysis

This executive summary uses a structured qualitative assessment of fully magnetically levitated ventricular assist devices. The approach considers peer-reviewed clinical evidence, regulatory and guideline materials, device-engineering literature, health-system characteristics, reimbursement considerations, and regional specialist-care capacity. Findings are organized across six required regions, six economic or institutional groups, and fifteen countries to identify recurring drivers, constraints, and implementation priorities. Conclusions are limited to evidence-supported themes and do not provide market estimates, sizing, shares, or forecasts.

Durable Adoption Depends on Demonstrated Patient Benefit and System Readiness

Fully MagLev ventricular assist devices represent an important engineering direction in durable mechanical circulatory support. Their long-term role will depend on consistent evidence that magnetic suspension translates into meaningful gains in safety, durability, quality of life, and care efficiency. Progress will require coordinated work among clinicians, regulators, payers, engineers, patients, and health systems. Organizations that combine reliable technology with strong training, monitoring, cybersecurity, equitable access, and transparent outcomes measurement will be best positioned to support responsible adoption.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fully MagLev Ventricular Assist Device Market, by Pump Placement
7.1. Introduction
7.2. Extracorporeal
7.3. Intracorporeal
7.3.1. Abdominal
7.3.2. Thoracic
7.4. Paracorporeal
8. Fully MagLev Ventricular Assist Device Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Pediatric
9. Fully MagLev Ventricular Assist Device Market, by Insurance Coverage Type
9.1. Introduction
9.2. Private
9.3. Public
10. Fully MagLev Ventricular Assist Device Market, by Application
10.1. Introduction
10.2. Bridge To Recovery
10.3. Bridge To Transplant
10.3.1. Long Term
10.3.2. Short Term
10.4. Destination Therapy
11. Fully MagLev Ventricular Assist Device Market, by End User
11.1. Introduction
11.2. Ambulatory Centres
11.3. Cardiac Care Centers
11.4. Hospitals
11.4.1. Community
11.4.2. Tertiary
12. Fully MagLev Ventricular Assist Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Fully MagLev Ventricular Assist Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Fully MagLev Ventricular Assist Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Berlin Heart GmbH
16.3. BiVACOR Inc.
16.4. CH Biomedical Co., Ltd.
16.5. CorWave SA
16.6. Evaheart Inc.
16.7. Jarvik Heart Inc.
16.8. Leviticus Cardio LLC
16.9. Medtronic plc
16.10. ReliantHeart Inc.
16.11. Shenzhen Core Medical Technology Co., Ltd.
16.12. Suzhou Tongxin Medical Devices Co., Ltd.
16.13. SynCardia Systems LLC
16.14. Teleflex Incorporated
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Fully MagLev Ventricular Assist Device Market, Years Considered for the Study
FIGURE 2. Global Fully MagLev Ventricular Assist Device Market, Research Design
FIGURE 3. Global Fully MagLev Ventricular Assist Device Market, Research Framework
FIGURE 4. Global Fully MagLev Ventricular Assist Device Market, Data Triangulation
FIGURE 5. Global Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2025 vs 2032 (%)
FIGURE 7. Global Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 9. Global Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2025 vs 2032 (%)
FIGURE 11. Global Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Fully MagLev Ventricular Assist Device Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Fully MagLev Ventricular Assist Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Fully MagLev Ventricular Assist Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Fully MagLev Ventricular Assist Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Fully MagLev Ventricular Assist Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Fully MagLev Ventricular Assist Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Fully MagLev Ventricular Assist Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Fully MagLev Ventricular Assist Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Fully MagLev Ventricular Assist Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Fully MagLev Ventricular Assist Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Fully MagLev Ventricular Assist Device Market Segmentation & Coverage
TABLE 2. Global Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 4. Global Extracorporeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Extracorporeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Extracorporeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intracorporeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intracorporeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intracorporeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Abdominal Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Abdominal Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Abdominal Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Thoracic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Thoracic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Thoracic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Paracorporeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Paracorporeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Paracorporeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 20. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 27. Global Private Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Private Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Private Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Public Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Public Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Public Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 34. Global Bridge To Recovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Bridge To Recovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Bridge To Recovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Bridge To Transplant Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Bridge To Transplant Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Bridge To Transplant Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Long Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Long Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Long Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Short Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Short Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Short Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Destination Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Destination Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Destination Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Centres Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Centres Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Centres Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Cardiac Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Cardiac Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Cardiac Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Community Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Community Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Community Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Tertiary Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Tertiary Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Tertiary Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 75. North America Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. North America Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 77. North America Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 78. North America Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 79. North America Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 80. North America Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. North America Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 82. North America Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. North America Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 84. Latin America Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Latin America Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 86. Latin America Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 87. Latin America Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 88. Latin America Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 89. Latin America Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Latin America Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 91. Latin America Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Latin America Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 93. Europe Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Europe Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 95. Europe Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 96. Europe Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 97. Europe Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 98. Europe Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Europe Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 100. Europe Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Europe Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 102. Middle East Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Middle East Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 104. Middle East Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 105. Middle East Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 106. Middle East Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 107. Middle East Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Middle East Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 109. Middle East Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Middle East Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. Africa Fully MagLev Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Africa Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 113. Africa Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 114. Africa Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 115. Africa Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 116. Africa Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Africa Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 118. Africa Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Africa Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 120. Global Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 123. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 124. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 126. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 128. ASEAN Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. ASEAN Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 130. GCC Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. GCC Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 132. GCC Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 133. GCC Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 134. GCC Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 135. GCC Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. GCC Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 137. GCC Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. GCC Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 139. European Union Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. European Union Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 141. European Union Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 142. European Union Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 143. European Union Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 144. European Union Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. European Union Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 146. European Union Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. European Union Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 148. BRICS Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. BRICS Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 150. BRICS Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 151. BRICS Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 152. BRICS Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 153. BRICS Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. BRICS Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 155. BRICS Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. BRICS Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 157. G7 Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. G7 Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 159. G7 Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 160. G7 Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 161. G7 Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 162. G7 Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. G7 Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 164. G7 Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. G7 Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. NATO Fully MagLev Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. NATO Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 168. NATO Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 169. NATO Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 170. NATO Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 171. NATO Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. NATO Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 173. NATO Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. NATO Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. Global Fully MagLev Ventricular Assist Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. United States Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 177. United States Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 178. United States Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 179. United States Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 180. United States Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 181. United States Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. United States Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 183. United States Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. United States Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 185. Canada Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 186. Canada Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 187. Canada Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 188. Canada Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 189. Canada Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 190. Canada Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Canada Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 192. Canada Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Canada Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 194. Mexico Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 195. Mexico Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 196. Mexico Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 197. Mexico Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 198. Mexico Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 199. Mexico Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Mexico Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 201. Mexico Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Mexico Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. Brazil Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 204. Brazil Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 205. Brazil Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 206. Brazil Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 207. Brazil Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 208. Brazil Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Brazil Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 210. Brazil Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Brazil Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 212. United Kingdom Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 213. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 214. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 215. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 216. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 217. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 219. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. United Kingdom Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 221. Germany Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 222. Germany Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 223. Germany Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 224. Germany Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 225. Germany Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 226. Germany Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Germany Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 228. Germany Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Germany Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 230. France Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 231. France Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 232. France Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 233. France Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 234. France Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 235. France Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. France Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 237. France Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. France Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 239. Russia Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 240. Russia Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 241. Russia Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 242. Russia Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 243. Russia Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 244. Russia Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Russia Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 246. Russia Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Russia Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. Italy Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 249. Italy Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 250. Italy Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 251. Italy Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 252. Italy Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 253. Italy Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Italy Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 255. Italy Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Italy Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 257. Spain Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 258. Spain Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 259. Spain Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 260. Spain Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 261. Spain Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 262. Spain Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. Spain Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 264. Spain Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Spain Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 266. China Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 267. China Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 268. China Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 269. China Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 270. China Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 271. China Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. China Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 273. China Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. China Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 275. India Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 276. India Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 277. India Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 278. India Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 279. India Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 280. India Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. India Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 282. India Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. India Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 284. Japan Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 285. Japan Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 286. Japan Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 287. Japan Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 288. Japan Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 289. Japan Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Japan Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 291. Japan Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Japan Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 293. Australia Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 294. Australia Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 295. Australia Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 296. Australia Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 297. Australia Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 298. Australia Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Australia Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 300. Australia Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Australia Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 302. South Korea Fully MagLev Ventricular Assist Device Market Size, 2017-2032 (USD Million)
TABLE 303. South Korea Fully MagLev Ventricular Assist Device Market Size, by Pump Placement, 2017-2032 (USD Million)
TABLE 304. South Korea Fully MagLev Ventricular Assist Device Market Size, by Intracorporeal, 2017-2032 (USD Million)
TABLE 305. South Korea Fully MagLev Ventricular Assist Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 306. South Korea Fully MagLev Ventricular Assist Device Market Size, by Insurance Coverage Type, 2017-2032 (USD Million)
TABLE 307. South Korea Fully MagLev Ventricular Assist Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. South Korea Fully MagLev Ventricular Assist Device Market Size, by Bridge To Transplant, 2017-2032 (USD Million)
TABLE 309. South Korea Fully MagLev Ventricular Assist Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. South Korea Fully MagLev Ventricular Assist Device Market Size, by Hospitals, 2017-2032 (US

Companies Mentioned

  • Abbott Laboratories
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • CH Biomedical Co., Ltd.
  • CorWave SA
  • Evaheart Inc.
  • Jarvik Heart Inc.
  • Leviticus Cardio LLC
  • Medtronic plc
  • ReliantHeart Inc.
  • Shenzhen Core Medical Technology Co., Ltd.
  • Suzhou Tongxin Medical Devices Co., Ltd.
  • SynCardia Systems LLC
  • Teleflex Incorporated